Slide 1: Annual General Meeting
Annual General Meeting SYDNEY, FRIDAY NOVEMBER 24 2006
Slide 2: Rob Phillips, Chairman
Slide 3: Board of Directors and Proxies Received
Board of Directors: Mr Rob Phillips Mr Gary Davey Mr Roman Zwolenski Proxies Received: 1,611,596 shares or less than 5% of the eran) shares in USCOM Limited. OS ;
Slide 4: Agenda
« Chairman’s presentation « Chief Executive’s presentation « Discussion of Financial Statement & Reports « Resolutions: Election of directors Remuneration Report Constitution Amendment * Questions
Slide 5: USCOM Ltd
_USCOM LTD
Slide 6: USCOM Achievements since VC in Oct
_USCOM Achievements: since VC in Oct 02 USseOMaes * Built the USCOM 1A. * Validated the device. * Achieved global regulatory approval. | - Finalist World Technology Awards - Time, Science, NYSE, CNN, Fortune. * Established partnerships with some of the worlds. | leading Hospitals and Medical Practit
Slide 7: USCOM Achievements since VC in Oct
| USCOMLTD _ _USCOM Achievements: since VC in Oct 02 -uSCOM has: * Significantly grown IP portfolio and value. Soy * Developed a product pathway for further generation — | products. eee * Developed sound management and IP development skills... * Achieved sales in major markets with multiple sales in
Slide 8: The USCOM Mission
i The USCOM Mission: NON-INVASIVE MANAGEMENT Of CIRCULATION
Slide 9: A diagnostic & therapy management tool for circulation
A diagnostic & therapy management tool for circulation..... And it is non-invasive
Slide 10: It is not a cardiology tool
lt is not a cardiology tool.... it is a comprehensive tool for managing circulation. Any person, any output, any where, any time!
Slide 11: The USCOM Solution
SCOMLTD _ The USCOM Solution: improved Haemodynamics Management Improved Outcomes
Slide 12: USCOM Applications
! ee ll USCOM Applications:
Slide 13: USCOM Applications
+ Electrophysiology « Drug trials _ + Haemodialysis a ee - o * Burns ocee ° Paediatrics. Int. Care ____* Heart Failure and Hypertension -Emarnanm, “Anaesthesia ‘Psychiatry “ Emergency : : vc * Pregnancy. * Liver transplantation “Animal research (ethical) ° Veterinary * Sports Medicine
Slide 14: USCOM is prepared for strategic development
* USCOM is prepared for strategic development. * Contact with major companies for strategic : a alliances in U.S. & Europe oe * incorporated USCOMINC for North America. * Recruiting independent directors with deal-making skills * In discussion with professional advisers to assess strategic options.
Slide 15: FY06 target of 100+ unit sales
* FY ‘06 target of 100+ unit sales — | * Distribution weakness in some overseas markets | * Addressing these issues * Distribution work essential for KOL network : ¢ Now have 150 customer sites worldwide ae * Sales continuing — but still in early stages of cycle
Slide 16: Crossing the Chasm technology adoption life cycle
oo | S gard 8 20g ife Cycle a 5 = Oo Oo @ = a the Chasm” a rrr—CC L — ing | - ion “Cross oo a a Moore, Adopt Geoffrey A. Adopters o a S vat a Janno a
Slide 17: Major technology advancements
3 major technology advancements Expansion of product pipeline: 5 new products Growth in IP portfolio: Now 24 patent applications Further validation against gold standard USA market launch after FDA clearance Regulatory approval for Japan, Korea & Taiwan Direct Sales team for Australia: 16 SALES IN 6
Slide 18: Financial Highlight
Financial Highlight: Total Revenue ; : $1, 716, 529 = Total Costs $5,158,809 Profit / (Loss) ($3,345 267) Cash receipts from customers __ $1,119,622 7 Net operating cash outflow = —- $3,187,788 : Cashinhandat30June06 —§ $7,222,322 —
Slide 19: Significant value in patent protected and in-house IP
USCOM has significant value in patent protected and In-house IP : . “Uscom has 24 separate patent cases directed to particular technologies with — three new cases being added this year” — Peter Treloar, Patent Attorney, Uscom 2005-6 Patent.Report. Building a product pipeline...
Slide 20: Core Patent description
Patent Description ye Application: USCOM Intracardiac CW Doppler: | - Core Patent Core Patent: The use of CW Ultrasound, transcutaneously _ (through the skin), for the monitoring of = cardiac flow. — Registered: June 1998. Published US Patents Office: May 2003
Slide 21: New Products in development
- 5 New Products in development : ee - Each supported with Patent Applications — - - Next Product release: OxyCOM 2007.
Slide 22: Slide 22
Slide 23: USCOM is ready for strategic change
* USCOM is ready for strategic change. * Building a global business — regulatory approvals ; and Intellectual Property in place. * Achieving credibility against established methods, sales traction in target markets . ¢« Dynamic growth with sound management. * Approaching breakeven with adequate cash
Slide 24: Slide 24
Slide 25: Unit sales by region
Asia 21 Australia 19 Europe 5 Other 1 TOTAL: 67. - Year-On-Year:+123% ff
Slide 26: Sales Revenue Growth
Sales Revenue Growth ~ $1,120,000 i@ $000s FY 05 FY 06 FY 03 FY 04
Slide 27: Q1 Cash Statement
_uscoM ue -Q1 Cash Statemen Appendix 4c)! FY 07 Net cash outflow * = $1 089,651 | Cash receipts from customers | $258,596 Cashin hand at30Sept06 = $6,132,671 *This includes $200,000 in manufacturing costs for inventory. The quarter showed a year-on-year improvement of $300,000.
Slide 28: Direct sales force in Australia
¢ First direct sales force appointed June 2005 : oe ¢ 19 units for FY 06 — 16 in second half * Representation in Sydney, Melbourne, Brisbane, Adelaide & Perth. « Experienced Sales & Marketing management appointed oo
Slide 29: Australian customer sites
: uscom LD _ New South Wales Queensland. Sydney Children’s Hospital, Anaesthetics Royal Brisbane & Women’s Hospital Sydney Children’s Hospital, ICU Logan Hospital, Brisbane... Children’s Hospital at Westmead, Sydney Beaudesert Hospital, Brisbane ~ CHISM, Sydney Hervey Bay Hospital oo ; Outback Famil
Slide 30: Objectives for FY 06/07
Objectives for FY 06/07 q Release next product: OxyCOM q Advance argument for medical reimbursement | q Achieve international recognition as standard of care 7 q Build optimum sales structures in US and Europe q Restructure Board & Management q Conclude international strategic alliances q TARGET: Ca
Slide 31: Primary Target Markets
PRIMARY TARGET MARKETS EMERGENCY: Now in clinical use at key sites in Aust, Asia, Europe & U.S. Collaborative study at 7 hospitals. Dr Emanuel Rivers Henry Ford Hospital, Detroit PAEDIATRICS: Now in clinical practice at 11 leading paediatrics sites. Great Ormond Street © Hospital, London
Slide 32: Primary Target Markets: Great Ormond Street Hospital
PRIMARY TARGET MARKETS “At Great Ormond Street Hospital, USCOM is the only method used for cardiac output in the past 2 years!"" — _-—s=DrdoeBrierley ts Paediatric Intensive Care . Great Ormond Street Hospital, London
Slide 33: Paediatrics Luminary Sites
| ie Paediatrics Luminary Sites x 117 « Children’s Hospital at Westmead » Sydney Children’s Hospital x 2 « Royal Children’s Hospital, Melbourne » Mercy Hospital, Velbourne » Duchess of Kent Children’s Hospital, Hong Kong » Shenzhen Children’s Hospital, Southern China » Saitama Paediatrics Hospital,
Slide 34: ae les by
ae les by Pei 7 ie ay ie Bi Lay 2 Le
Slide 35: Validation
Validation « Over 50 studies presented ¢ 7 published in peer-reviewed journals Oi @ ANNALS OF THORACIC
Slide 36: Validation study results
| uscom' LTD i : Amanda Corley (PCH): ANZICS Oct 06 “Almost Perfect Agreement’ Between UscoM, PAC. & Fick ; USCOM “Reliable & Accurate for measuring co” Learning Curve “Satisfactorily Short” “Nursing Staff can non-invasively determine CO” Measurement time down from 25 mins to 5 in difficult patient
Slide 37: Emergency medicine study
* 107 patients measured by 200 operators sae -5 to 10 minutes training The journal of Emergency Medicine * Less than 10% variation. - Up to 25% variation for PAC “standard” 2 * Step towards adoption in Emergency Care.
Slide 38: Conclusion
—USCOMLTD CONCLUSION: _ “... showed marked benefit in monitoring “3 response to therapy.”
Slide 39: Slide 39
Slide 40: The measure of life
The measure Of life.
Slide 41: Slide 41
Slide 42: Information relating to Resolutions
Information relating to Resolutions included in the = Notice of Meeting, dated 25 October 2006 Resolution 1 - Election of directors Resolution 2 - Remuneration Report — Resolution 3 - Constitution amendment QUESTIONS
Slide 43: Allocation of Proxies
_ USCOMLTD ALLOCATION OF PROXIES: The Chairman intends to vote in favour of all resolutions. FOR AGAINST ABSTAIN - 1. Election of Mr R. Phillips 1,224,690 24,000 312 2. Adoption of Remuneration Report 1,210,002 36,000 3,000 3. Constitution Amendment 1,073,213 5,789 : oO
Slide 44: Resolution - Election of directors
Resolution 1 - Election of directors ; To consider and, if thought fit, to pass the following resolution as an ordinary resolution of the Company: — ‘That Mr Rob Phillips who retires by rotation in accordance with the Company's constitution and being eligible, offers himself for re-election, be re-e
Slide 45: Resolution - Remuneration Report
Resolution 2 - Remuneration Report - To consider and, if thought fit, to pass the. following non-binding resolution as an ordinary resolution of the. Company: - ‘That the Company’s Remuneration Report which i is set out on pages 26 to 29 of the 2006 annual report be e adopted. y
Slide 46: Resolution - Constitution amendment
Resolution 3 - Constitution amendment. a To consider and if thought fit, to pass the following : resolution as an ordinary resolution of the Company: ‘That the Company's Constitution be amended to provide for the sale of non marketable parcels of shares by the Company in the manner described in the
Slide 47: Questions